Clopidogrel bioactivation and risk of bleeding in patients cotreated with angiotensin-converting enzyme inhibitors after myocardial infarction: a proof-of-concept study.
about
Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapyPharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme InhibitorsA population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors.Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalaprilCES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril.The Impact of CYP2C19 Loss-of-Function Polymorphisms, Clinical, and Demographic Variables on Platelet Response to Clopidogrel Evaluated Using Impedance Aggregometry.Identifying clinically relevant sources of variability: The clopidogrel challenge.Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans.
P2860
Q26852535-94893EE5-B815-4EF6-8DA5-A9B5A7A3D34AQ28554328-5E690DC2-4584-4EA7-AB43-1107E07DF598Q36125455-1E862C8E-58E1-47B2-A643-D31847C37226Q36243667-291CFA90-EABD-4482-8252-F638527A85B0Q36896568-D0B4C42B-575C-47B2-A1B6-7D05403ADF1BQ40000336-D20E271C-12EF-4037-9890-7D8AA1064146Q50591900-916DF225-984E-4A09-9035-D4878C1B0F8FQ53601038-921B6B64-777A-49DF-AB22-3FBEC820F87E
P2860
Clopidogrel bioactivation and risk of bleeding in patients cotreated with angiotensin-converting enzyme inhibitors after myocardial infarction: a proof-of-concept study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Clopidogrel bioactivation and ...... ion: a proof-of-concept study.
@en
Clopidogrel bioactivation and ...... ion: a proof-of-concept study.
@nl
type
label
Clopidogrel bioactivation and ...... ion: a proof-of-concept study.
@en
Clopidogrel bioactivation and ...... ion: a proof-of-concept study.
@nl
prefLabel
Clopidogrel bioactivation and ...... ion: a proof-of-concept study.
@en
Clopidogrel bioactivation and ...... ion: a proof-of-concept study.
@nl
P2093
P2860
P50
P356
P1476
Clopidogrel bioactivation and ...... ion: a proof-of-concept study.
@en
P2093
H B Rasmussen
J S Markowitz
K E Kristensen
P2860
P304
P356
10.1038/CLPT.2014.183
P407
P577
2014-09-15T00:00:00Z